• By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.
In the last 7 days
Moderna applies for review of updated Covid-19 vaccine Pharmaceutical Technology12:03 10-Jun-24
In the last month
FDA Roundup: June 7, 2024 U.S. Food and Drug Administration (Press Release)21:00 7-Jun-24
FDA recommends updated Covid-19 vaccines targeting JN.1 Pharmaceutical Technology05:13 7-Jun-24
FDA panel supports switch to JN.1 for fall COVID vaccines Center for Infectious Disease Research and Policy22:06 5-Jun-24
Current COVID boosters offer good protection against severe outcomes but less so against JN.1 Center for Infectious Disease Research and Policy21:12 30-May-24
view more headlines
15 Jun 12:22

About our JN.1 news

Latest news on the JN.1 COVID-19 variant: stay up-to-date with the developments of the JN.1 variant through NewsNow's focused feed.

The JN.1 COVID-19 variant, a subvariant of the Omicron lineage BA.2.86, is currently under close monitoring by public health agencies worldwide due to its increased transmission rate. It first emerged in the United States in September and has since spread to multiple countries, including the UK.

Our JN.1 dedicated feed offers comprehensive insights into the evolution, spread, and impact of this new subvariant of the SARS-CoV-2 virus, which is closely monitored by global health organisations. It is a crucial tool for health professionals, researchers, policymakers, and anyone keen on understanding the dynamics of this emerging health challenge.

Our coverage delves into various aspects of JN.1, including its transmissibility, the effectiveness of current vaccines against it, and the public health responses being adopted globally. We explore in-depth analyses of JN.1's genetic mutations, how it compares with previous COVID-19 variants, and its implications for future virus management strategies. The feed also looks at the variant's global spread, with specific attention to its impact in countries like the United States and the UK, providing a nuanced perspective on the variant's progression and the concerted efforts to contain it.

For those following pandemic trends, healthcare experts, and those interested in public health developments, NewsNow's feed on the JN.1 variant is an indispensable resource. We compile the latest news, expert analyses, and comprehensive reports from reliable sources, offering a thorough and balanced view of the evolving situation surrounding the JN.1 COVID-19 variant.

Publication filters

Headline Density

Sorry, no headlines or news topics were found. Please try different keywords.